{"filing":{"accession_number":"0001438133-26-000070","cik":"0001438133","ticker":"TNDM","company_name":"TANDEM DIABETES CARE INC","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"tndm-20260520.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000070/tndm-20260520.htm"},"events":[{"id":9506,"run_id":8337,"accession_number":"0001438133-26-000070","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Tandem Diabetes Care held its 2026 Annual Meeting of Stockholders on May 20, 2026, with shareholders voting on six proposals: election of nine directors, advisory vote on named executive officer compensation, approval of an amended 2023 Long-Term Incentive Plan increasing authorized shares by 3,260,000, amendments to the Certificate of Incorporation regarding director removal and officer liability limitations, and ratification of Ernst \u0026 Young LLP as independent auditor. All proposals passed with substantial majorities.","company_name":"TANDEM DIABETES CARE INC","ticker":"TNDM","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1160,"accession_number":"0001438133-26-000070","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The filing discloses stockholder-approved amendments to the Certificate of Incorporation that materially modify shareholder rights and governance protections, including removal of directors with or without cause and limitation of officer liability. While this is a governance matter affecting the rights of security holders, it does not fit neatly into the more specific event categories (it is not a shareholder vote result per se, but rather the implementation of amendments approved at a shareholder meeting). The amendments are material to investors as they alter fundamental governance and liability protections, warranting disclosure under Item 3.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1161,"accession_number":"0001438133-26-000070","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Long-Term Incentive Plan increasing authorized shares by 3,260,000 shares. This is a compensatory arrangement affecting equity grants and incentive compensation for officers and directors, fitting the exec_compensation category. The material increase in share authorization and shareholder approval make this material to investors assessing dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1162,"accession_number":"0001438133-26-000070","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder voting results from the May 20, 2026 Annual Meeting. The filing presents final voting tallies for six proposals: election of nine directors, advisory vote on named executive officer compensation, approval of an amended equity plan, amendments to the Certificate of Incorporation regarding director removal and officer liability, and ratification of Ernst \u0026 Young LLP as independent auditor. All proposals passed with substantial majorities, making this a material disclosure of shareholder actions that affects the composition and governance of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1160,"accession_number":"0001438133-26-000070","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The filing discloses stockholder-approved amendments to the Certificate of Incorporation that materially modify shareholder rights and governance protections, including removal of directors with or without cause and limitation of officer liability. While this is a governance matter affecting the rights of security holders, it does not fit neatly into the more specific event categories (it is not a shareholder vote result per se, but rather the implementation of amendments approved at a shareholder meeting). The amendments are material to investors as they alter fundamental governance and liability protections, warranting disclosure under Item 3.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"TANDEM DIABETES CARE INC","ticker":"TNDM","filing_date":"2026-05-21"},{"id":1161,"accession_number":"0001438133-26-000070","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Long-Term Incentive Plan increasing authorized shares by 3,260,000 shares. This is a compensatory arrangement affecting equity grants and incentive compensation for officers and directors, fitting the exec_compensation category. The material increase in share authorization and shareholder approval make this material to investors assessing dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"TANDEM DIABETES CARE INC","ticker":"TNDM","filing_date":"2026-05-21"},{"id":1162,"accession_number":"0001438133-26-000070","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder voting results from the May 20, 2026 Annual Meeting. The filing presents final voting tallies for six proposals: election of nine directors, advisory vote on named executive officer compensation, approval of an amended equity plan, amendments to the Certificate of Incorporation regarding director removal and officer liability, and ratification of Ernst \u0026 Young LLP as independent auditor. All proposals passed with substantial majorities, making this a material disclosure of shareholder actions that affects the composition and governance of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:41.612933+00:00","company_name":"TANDEM DIABETES CARE INC","ticker":"TNDM","filing_date":"2026-05-21"}]}